RxDoctor Payments DataLook up a doctor →

Mary Abuzzahab

Pediatric Endocrinology · Saint Paul, MNNPI 1174515274

Payments from drug & device makers

$1,233,331in general payments, 2019–2025

Across 2,872 payments — averaging $429.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Rhythm Pharmaceuticals, Inc.$442K
  • Novo Nordisk AS$276K
  • Soleno Therapeutics, Inc.$240K
  • Ascendis Pharma Endocrinology Inc$208K
  • Neurocrine Biosciences, Inc.$29K
  • Novo Nordisk Health Care AG$17K
  • plus $21K from 5 others
$3,250in research payments, 2019–2025

Across 2 payments — averaging $1625.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Mannkind Corporation$3K

General payments by program year

20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,233,331 in reported general payments places this provider in the 90th percentile of 25 pediatric endocrinology providers in Minnesota.

See all pediatric endocrinology providers in Minnesota

Other pediatric endocrinology in Saint Paul

See the full list for Minnesota

Where these figures come from

Is this you, or does something look wrong? →